Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer

Fibroblast growth factor receptor (FGFR) inhibitors (FGFRis) are a potential therapeutic option for squamous non-small cell lung cancer (Sq-NSCLC). Because appropriate patient selection is needed for targeted therapy, molecular profiling is key to discovering candidate biomarker(s). Multiple FGFR ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Moes-Sosnowska, Joanna, Chorostowska-Wynimko, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991910/
https://www.ncbi.nlm.nih.gov/pubmed/35402233
http://dx.doi.org/10.3389/fonc.2022.780650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991910/
https://www.ncbi.nlm.nih.gov/pubmed/35402233
http://dx.doi.org/10.3389/fonc.2022.780650

Ejemplares similares